Family and Rural Medicine Clerkships Flashcards
(706 cards)
USPSTF Abdominal Aortic Aneurysm Screening?
Men Ages 65 to 75 Years who Have Ever Smoked: One-time ultrasound AAA screening
Men Ages 65 to 75 Years who Have Never Smoked: Selectively offer ultrasound AAA screening
Women Ages 65 to 75 Years who Have Ever Smoked: Insufficient evidence
Women who have never smoked: Recommend against AAA screening
USPSTF Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care
Adults aged 18 and older: screen for alcohol misuse and provide persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce alcohol misuse
Adolescents (under 18 years of age): insufficient evidence
USPSTF Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening
Adults aged 40 to 70 years who are overweight or obese: recommends screening for abnormal blood glucose as part of cardiovascular risk assessment. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity.
USPSTF Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication
Adults aged 50 to 59 years with a ≥10% 10-year CVD risk: recommends low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC) given that the patient is not at increased risk for bleeding, has a life expectancy of at least 10 years, and is willing to take low-dose aspirin daily for at least 10 years.
Adults aged 60 to 69 years with a ≥10% 10-year CVD risk:
The decision to initiate low-dose aspirin use for the primary prevention of CVD and CRC in adults aged 60 to 69 years who have a 10% or greater 10-year CVD risk should be an individual one. Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. Persons who place a higher value on the potential benefits than the potential harms may choose to initiate low-dose aspirin.
Adults younger than 50 years, Adults aged 70 years or older: insufficient evidence
USPSTF Asymptomatic Bacteriuria in Adults: Screening
Pregnant Women at 12 to 16 Weeks’ Gestation: recommends screening for asymptomatic bacteriuria with urine culture for pregnant women at 12 to 16 weeks’ gestation or at their first prenatal visit, if later.
Men and Nonpregnant Women: recommends against screening for asymptomatic bacteriuria
USPSTF Autism Spectrum Disorder in Young Children: Screening
Children aged 18 to 30 months: current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.
USPSTF Bacterial Vaginosis in Pregnancy to Prevent Preterm Delivery: Screening
Asymptomatic Pregnant Women, Low Risk: recommends against screening for bacterial vaginosis in asymptomatic pregnant women at low risk for preterm delivery.
Asymptomatic Pregnant Women, High Risk: current evidence is insufficient to assess the balance of benefits and harms of screening for bacterial vaginosis in asymptomatic pregnant women at high risk for preterm delivery.
USPSTF Bladder Cancer in Adults: Screening
Asymptomatic Adults: current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.
USPSTF Blood Pressure in Children and Adolescents (Hypertension): Screening
Children and Adolescents: current evidence is insufficient to assess the balance of benefits and harms of screening for primary hypertension in asymptomatic children and adolescents to prevent subsequent cardiovascular disease in childhood or adulthood.
USPSTF BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing
Women who have Family Members with Breast, Ovarian, Tubal, or Peritoneal Cancer: recommends that primary care providers screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with 1 of several screening tools designed to identify a family history that may be associated with an increased risk for potentially harmful mutations in breast cancer susceptibility genes (BRCA1 or BRCA2). Women with positive screening results should receive genetic counseling and, if indicated after counseling, BRCA testing.
Women Whose Family History is not Associated with an Increased Risk: recommends against routine genetic counseling or BRCA testing for women whose family history is not associated with an increased risk for potentially harmful mutations in the BRCA1 or BRCA2 genes.
USPSTF Breast Cancer: Medications for Risk Reduction
Women, Increased Risk for Breast Cancer: recommends that clinicians engage in shared, informed decision making with women who are at increased risk for breast cancer about medications to reduce their risk. For women who are at increased risk for breast cancer and at low risk for adverse medication effects, clinicians should offer to prescribe risk-reducing medications, such as tamoxifen or raloxifene.
Women, Not at Increased Risk for Breast Cancer: recommends against the routine use of medications, such as tamoxifen or raloxifene, for risk reduction of primary breast cancer in women who are not at increased risk for breast cancer.
USPSTF Breast Cancer: Screening
Women aged 50 to 74 years: recommends biennial screening mammography for women aged 50 to 74 years.
Women aged 40 to 49 years: decision to start screening mammography in women prior to age 50 years should be an individual one. Women who place a higher value on the potential benefit than the potential harms may choose to begin biennial screening between the ages of 40 and 49 years. (Potential harms = over-diagnosis, over-treatment, biopsies etc). Women with a parent, sibling, or child with breast cancer are at higher risk for breast cancer and thus may benefit more than average-risk women from beginning screening in their 40s.
Women aged 75 years or older: insufficient evidence
All women: USPSTF concludes that the current evidence is insufficient to assess the benefits and harms of digital breast tomosynthesis (DBT) as a primary screening method for breast cancer.
Women with dense breasts: current evidence is insufficient to assess the balance of benefits and harms of adjunctive screening for breast cancer using breast ultrasonography, magnetic resonance imaging, DBT, or other methods in women identified to have dense breasts on an otherwise negative screening mammogram.
USPSTF Breastfeeding: Primary Care Interventions
Pregnant women, new mothers, and their children: recommends providing interventions during pregnancy and after birth to support breastfeeding.
USPSTF Carotid Artery Stenosis: Screening
General Adult Population: recommends against screening for asymptomatic carotid artery stenosis in the general adult population.
USPSTF Celiac Disease: Screening
Asymptomatic adults, adolescents, and children: current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.
USPSTF Cervical Cancer: Screening
Women 21 to 65 (Pap Smear) or 30-65 (in combo with HPV testing): recommends screening for cervical cancer in women age 21 to 65 years with cytology (Pap smear) every 3 years or, for women age 30 to 65 years who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years.
Women younger than 30 years, HPV testing: recommends against screening for cervical cancer with HPV testing, alone or in combination with cytology, in women younger than age 30 years.
Women younger than 21: recommends against screening for cervical cancer in women younger than age 21 years.
Women Older than 65, who have had adequate prior screening: recommends against screening for cervical cancer in women older than age 65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer.
Women who have had a hysterectomy: recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade precancerous lesion (cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.
USPSTF Child Maltreatment: Primary Care Interventions
Children: current evidence is insufficient to assess the balance of benefits and harms of primary care interventions to prevent child maltreatment. This recommendation applies to children who do not have signs or symptoms of maltreatment.
USPSTF Chlamydia and Gonorrhea: Screening
Sexually Active Women: recommends screening for chlamydia and gonorrhea in sexually active women age 24 years and younger and in older women who are at increased risk for infection.
Sexually Active Men: current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.
USPSTF Chronic Kidney Disease: Screening
Asymptomatic Adults: evidence is insufficient to assess the balance of benefits and harms of routine screening for chronic kidney disease (CKD) in asymptomatic adults.
USPSTF Chronic Obstructive Pulmonary Disease: Screening
Asymptomatic adults: recommends against screening for chronic obstructive pulmonary disease (COPD) in asymptomatic adults.
USPSTF Cognitive Impairment in Older Adults: Screening
Older Adults: current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment.
USPSTF Colorectal Cancer: Screening
Adults aged 50 to 75 years: recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years.
Adults aged 76 to 85 years: The decision to screen for colorectal cancer in adults aged 76 to 85 years should be an individual one, taking into account the patient’s overall health and prior screening history.
Adults in this age group who have never been screened for colorectal cancer are more likely to benefit.
Screening would be most appropriate among adults who 1) are healthy enough to undergo treatment if colorectal cancer is detected and 2) do not have comorbid conditions that would significantly limit their life expectancy.
USPSTF Coronary Heart Disease: Screening Using Non-Traditional Risk Factors
Men and Women with No History of CHD: USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors studied to screen asymptomatic men and women with no history of CHD to prevent CHD events.
USPSTF Coronary Heart Disease: Screening with Electrocardiography
Adults at Low Risk: SPSTF recommends against screening with resting or exercise electrocardiography (ECG) for the prediction of coronary heart disease (CHD) events in asymptomatic adults at low risk for CHD events. (D)
Adults at Intermediate or High Risk: USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG for the prediction of CHD events in asymptomatic adults at intermediate or high risk for CHD events. (I)